Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream

NCT00193908 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

333

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Cavilon (TM) Durable Barrier Cream
DRUG: Sorbolene
RADIATION: Radiotherapy

Sponsor

Trans Tasman Radiation Oncology Group

Collaborators

[object Object]